1. gipsyrose85
2. sneekygit
3. jojo499009
1.jojo499009 07/12/2018
resTORbio Announces Science Translational Medicine Publication of Phase 2a Data Showing Improvement in Immune Function and Decreased Infection Rates in People Aged 65 Years and Older
2.sneekygit 01/25/2018
Company has priced 5.67mm shares at a mid-range price of $15.00
3.gipsyrose85 07/25/2018
Announces 'positive' topline results from its dose-ranging Phase 2b clinical trial
4.gipsyrose85 03/30/2018
resTORbio Reports Fourth Quarter and Full Year 2017 Financial Results
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW